Davide Molho
CEO, BioAgilytix
Davide Molho is the CEO of BioAgilytix, responsible for the company’s vision, growth strategy, and operational performance. He fosters innovation while addressing operational needs across its laboratories. Previously, he held senior roles at Charles River Laboratories, where he served as President and COO and was CEO at Evolution Research Group and Viroclinics Biosciences. Davide holds a degree in veterinary medicine from Milan University and began his career in R&D at Bracco.